Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 18;5(1):00225-2018.
doi: 10.1183/23120541.00225-2018. eCollection 2019 Feb.

Research highlights from the 2018 European Respiratory Society International Congress: airway disease

Florence Schleich  1 , Andras Bikov  2   3 , Alexander G Mathioudakis  2   3 , Melissa McDonnell  4 , Cecilia Andersson  5 , Matteo Bonini  6   7 , Lena Uller  8 , Marco Idzko  9 , Dave Singh  10 , Jose Luis Lopez-Campos  11   12 , Apostolos Bossios  13   14 , Ian M Adcock  7 , Omar Usmani  7 , Antonio Spanevello  15 , Sara J Bonvini  7
Affiliations
Review

Research highlights from the 2018 European Respiratory Society International Congress: airway disease

Florence Schleich et al. ERJ Open Res. .

Abstract

The annual European Respiratory Society (ERS) International Congress (held in Paris in 2018) was once again a platform for discussion of the highest-quality scientific research, cutting-edge techniques and innovative new therapies within the respiratory field. This article discusses only some of the high-quality research studies presented at this year's Congress, with a particular focus on airway diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and cough, as presented through Assembly 5 of the ERS (Airway Diseases: Asthma and COPD). The authors establish the key take-home messages of these studies, compare their findings and place them in the context of current understanding.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: F. Schleich has nothing to disclose. Conflict of interest: A. Bikov has nothing to disclose. Conflict of interest: A.G. Mathioudakis reports grants and personal fees from Boehringer Ingelheim, and personal fees from GlaxoSmithKline, outside the submitted work. Conflict of interest: M. McDonnell reports grants from the Health Research Board, Ireland, outside the submitted work. Conflict of interest: C. Andersson has nothing to disclose. Conflict of interest: M. Bonini has nothing to disclose. Conflict of interest: L. Uller has nothing to disclose. Conflict of interest: M. Idzko has nothing to disclose. Conflict of interest: D. Singh reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Glenmark, Menarini, Mundipharma, Novartis, Pfizer, Pulmatrix, Therevance and Verona, and personal fees from Cipla and Peptinnovate, outside the submitted work. Conflict of interest: J.L. Lopez-Campos reports personal fees and nonfinancial support from Boehringer, Grifols, Novartis, Chiesi, AstraZeneca and GSK, personal fees from Teva, Rovi, Ferrer, Bial, Esteve and Gebro Pharma, and grants, personal fees and nonfinancial support from Menarini, outside the submitted work. Conflict of interest: A. Bossios reports personal fees and other support for consultancy from AstraZeneca, Teva and GSK, outside the submitted work. Conflict of interest: I.M. Adcock has nothing to disclose. Conflict of interest: O. Usmani reports grants and personal fees from AstraZeneca, Boehringer Ingelheim and Chiesi, personal fees from Aerocrine, Napp, Mundipharma, Sandoz, Prosonix, Takeda, Zentiva Cipla and Pearl Therapeutics, and grants from GlaxoSmithKline and Edmond Pharma, outside the submitted work. Conflict of interest: A. Spanevello has nothing to disclose. Conflict of interest: S.J. Bonvini has nothing to disclose.

References

    1. World Health Organization Chronic respiratory diseases: asthma. www.who.int/respiratory/asthma/en/.
    1. Pavord ID, Bush A, Holgate S. Asthma diagnosis: addressing the challenges. Lancet Respir Med 2015; 3: 339–341. - PubMed
    1. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–813. - PubMed
    1. Nawijn M, Carpaij O, Viera Braga F, et al. . Novel cell types and altered cell states in asthma revealed by single-cell RNA sequencing of airway wall biopsies. Eur Respir J 2018; 52: Suppl. 62, OA505.
    1. Tokunaga Y, Imaoka H, Morimatsu Y, et al. . Role of CD63 in human fatal asthma and murine asthma model. Eur Respir J 2018; 52: Suppl. 62, PA648.